






Fig. 1-1. Two types of protein N-myristoylation 
A. Co-translational N-myristoylation.  
B. Post-translational N-myristoylation occurring on caspase-cleavage products of specific caspase 
     substrates. 
Fig. 1-2. Functional modulation of N-myristoylated proteins 
a ) elimination of polybasic motif by binding of specific protein. b ) elimination of positive charges by 








Fig. 1-3. Protein N-myristoylation in disease 
A. Enzymatic removal of  N-myristoylated N-terminal moiety by the Shigella virulence factor 
IpaJ. (Shigellosis) 
B. Protein N-myristoylation resulting from point mutation. (Noonan-like syndrome) 
C. Inhibition of post-translational N-myristoylation.  disease) 





Fig. 1-4. Detection of protein N-myristoylation by bioorthogonal reaction 
A. Cu (I)-catalyzed azide-alkyne cycloaddition. B. Process for metabolic labeling of cellular N-
myristoylated proteins with myristic acid analogues. Synthetic-alkynyl fatty acids are added to cultured 
cells and metabolically incorporated into proteins. After cell lysis, the alkynyl group is chemoselectively 
ligated to azide-biotin-fluorophore by a Cu (I)-catalyzed azide-alkyne cycloaddition reaction. The 
tagged proteins are separated by gel electrophoresis and detected by in-gel fluorescence (a) or 

















Fig. 2-1. Protein Lunapark is an N-myristoylated integral membrane protein.  
A. Structure and N-terminal sequence of cDNA clones analyzed in this study. B. mRNAs encoding ARF1-, 
SERINC1-, KIAA1609-, Lunapark- and ZZEF1-FLAG were translated in vitro in the presence of 
[3H]leucine ([3H]Leu) or [3H]myristic acid ([3H]Myr) using an insect cell-free protein synthesis system. The 
labeled translation products were analyzed by SDS-PAGE and fluorography. C. cDNAs encoding ARF1-, 
SERINC1-, KIAA1609-, Lunapark- and ZZEF1-FLAG were transfected in to COS-1 cells, and their 
expression and N-myristoylation of the products were evaluated by Western blotting analysis and 
[3H]myristic acid labeling, respectively. D. KIAA1609-FLAG and Lunapark-FLAG were expressed in 
COS-1 cells, and subcellular fractionation experiments were performed. Hsp70 was used as a cytosolic 
marker protein and PDI was used as membrane/organelle marker protein. C, cytosolic fraction; M, 
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Fig. 2-2. Structure of protein Lunapark.
Alignment of the N-terminal sequences and the transmembrane domains (TMDs) of the Lunapark 
family of proteins is shown. N- myristoylation motifs are shown in red in the N-terminal sequence. 
Hydrophobic amino acids are shown in grey and charged amino acids in blue in the transmembrane 














Lunapark Zinc finger motifTMD TMD
N-myristoylation
motif
42 64 75 97
Danio rerio 37 102
Xenopus laevis 37 102
Pongo abelii 37 102
Mus musculus 37 102






Fig. 2-3.  Detection of protein N-myristoylation in in vitro-synthesized protein Lunapark by MS 
analysis.  
A. Purified in vitro-synthesized protein Lunapark (1 g) was separated by electrophoresis in an SDS-
PAGE gel (12.5%). B. MALDI-MS of the tryptic peptides from in vitro-synthesized protein Lunapark. 
The peaks of the tryptic peptides derived from in vitro-synthesized protein Lunapark are indicated by 
stars. C. MS/MS analysis was performed for the peak at m/z 846.55. The identified N-myristoylated N-
terminal sequence is shown. 
Fig. 2-4.  Analysis of membrane integration and membrane topology of protein Lunapark.
A. Structure of pro-GLC-TNF, Lunapark-TM1- GLC-TNF, and Lunapark-TM1-G2A-GLC-TNF for analysis of 
the function of transmembrane domain 1 (TM1) of protein Lunapark. B. cDNAs encoding pro-GLC-TNF, 
Lunapark-TM1-GLC-TNF were transfected in to COS-1 cells, and their secretion and expression in total cell 
lysates were evaluated by Western blotting analysis using an anti-TNF antibody. N-glycosylation of the expressed 
proteins in total cell lysates was determined by the change in its molecular weight after treatment with 
glycopeptidase F (GPF). S, cell culture supernatant; T, total cell lysates. C. cDNAs encoding Lunapark-TM1- 
GLC-TNF and Lunapark-TM1-G2A-GLC-TNF were transfected in to COS-1 cells, and their expression and the 
N-myristoylation of the products in total cell lysates were evaluated by Western blotting analysis and [3H]myristic 
acid ([3H]Myr) labeling, respectively. D. Structure of Lunapark-TM1-GLC-TNF, Lunapark- TM1/2-GLC-TNF, 
and Lunapark-GLC-TNF for analysis of the function of transmembrane domain 2 (TM2) of protein Lunapark. E. 
cDNAs encoding Lunapark-TM1-GLC-TNF, Lunapark-TM1/2-GLC-TNF, and Lunapark-GLC-TNF were 
transfected in to COS-1 cells, and their expression in total cell lysates was evaluated by Western blotting analysis. 
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Fig. 2-5. Analysis of the role of transmembrane domain 2 and its flanking region of protein 
Lunapark on the membrane topology formation of protein Lunapark. 
 A. Structure of H14-TNF, H14-TNF-Lunapark-TM2, and H14-TNF-Lunapark- TM2 to analyze 
the function of transmembrane domain 2 (TM2) of protein Lunapark. B. cDNAs encoding H14-
TNF, H14-TNF-Lunapark-TM2, and H14-TNF-Lunapark- TM2 were transfected in to COS-1 
cells, and their secretion and expression in total cell lysates were evaluated by Western blotting 





















Fig. 2-6.  Protein N-myristoylation plays a critical role in the ER morphological change induced by 
protein Lunapark.  
A. Detection of protein N-myristoylation of Lunapark-FLAG expressed in HEK293T cells. cDNAs encoding 
Lunapark-FLAG and Lunapark-G2AFLAG were transfected in to HEK293T cells, and their expression and the 
N-myristoylation of the products in total cell lysates were evaluated by Western blotting analysis and 
[3H]myristic acid ([3H]Myr) labeling, respectively. B. Intracellular localization of Lunapark-FLAG and 
Lunapark- G2A-FLAG was determined by immunofluorescence staining of HEK293T cells transfected with 





















Fig. 2-7.  Protein Lunapark mainly localized to the peripheral ER and induced the ER morphological 
change in an N-myristoylationdependent manner. 
 A. EGFP-Sec61  cDNA alone, Lunapark-FLAG cDNA and EGFP-Sec61  cDNA, or Lunapark-G2A-FLAG 
cDNA and EGFP-Sec61  cDNA, were transfected in to HEK-293T cells, and distribution of these proteins 
was evaluated by immunofluorescence analysis or fluorescence microscopic analysis. b', 
and i' show a close-up and over-exposed image of the area surrounded by a white box in b, c, d, e, f, g, h, and i, 
respectively. B. EGFP-Sec61  cDNA was transfected in to HEK-293T cells and the distribution of the protein 

























Fig. 2-8. Quantitative analysis of the ER morphological change in HEK293T cells induced by Lunapark-
FLAG (WT) and Lunapark-G2A-FLAG (G2A).
HEK293T cells were cotransfected with EGFP-Sec61  and Lunapark-FLAG (or Lunapark-G2A-FLAG), and 
quantitative analysis of the ER morphological change was performed by fluorescence microscopic observation of 
100 cells expressing both EGFP-Sec61  and protein Lunapark (EGFP-positive/immunofluorescence-positive 
cells). A. Left panels (a, d) show merged image of EGFP fluorescence, immunofluorescence, and Hoechst 
staining. Right panels (b, c, e, f) show a close-up and over-exposed image of the area surrounded by a white box 
in the left panels (a, d). B. The extent of ER morphological changes is expressed as a percentage of the number of 
cells having highly tubular, partially tubular, and non-tubular image of EGFP-Sec61  against the total number of 
EGFP-positive/ immuno-fluorescence-positive cells. Data are expressed as mean  SD for four independent 




























Fig. 2-9.  Role of the zinc finger motif of protein Lunapark in the ER morphological change induced by 
protein Lunapark. 
 A. Alignment of the zinc finger motif of Lunapark protein family members. Highly conserved cysteine 
residues are indicated by red arrows. B. Detection of protein N-myristoylation of Lunapark-CtoA-FLAG 
expressed in HEK293T cells. cDNAs encoding Lunapark-FLAG, Lunapark-G2A-FLAG, and Lunapark- CtoA-
FLAG were transfected in to HEK293T cells, and their expression and the N-myristoylation of the products in 
the total cell lysates were evaluated by Western blotting analysis and [3H]myristic acid ([3H]Myr) labeling, 
respectively. C. Intracellular localization of Lunapark-FLAG, Lunapark-G2A-FLAG, and Lunapark-CtoA-
FLAG was determined by immunofluorescence staining of HEK293T cells transfected with cDNAs encoding 
these three proteins using an anti-FLAG antibody. Right panel shows a close-up view of the area surrounded by 
a white box in the immunofluorescence image. D. Quantitative analysis of the ER morphological change in 
HEK293T cells induced by Lunapark-FLAG (WT), Lunapark-G2A-FLAG (G2A), and Lunapark- CtoA-FLAG 
(CtoA). cDNAs encoding Lunapark-FLAG, Lunapark-G2A-FLAG, and Lunapark-CtoA-FLAG were 
transfected in to HEK293T cells and the morphological change of the ER in each cell was determined by 
immunofluorescence staining and the extent of the ER morphological change was compared. The extent of ER 
morphological changes is expressed as a percentage of the number of cells with highly tubular, partially tubular, 
and non-tubular ER against the total number of transfected cells. Data are expressed as mean  SD for five 



















































Table 3-1 (1) 
The nucleotide sequences of oligonucleotides used in this study 
Primer Primer Sequence 
Primer-N1 EcoRI-tAct11-N -ATATGAATTCCGGTTCCGCTGCCCT-
Primer-C1 XbaI-stop-Flag-C GCGCTCTAGATTACTTGTCATCGTC 
KOP01999 EcoRV-FXC01999 10aa-EcoRI-N ATCATGGGCGCGAACAATGGCAAACAGTACGGCG 
KOP01999R EcoRI-FXC01999 10aa-EcoRV-C AATTCGCCGTACTGTTTGCCATTGTTCGCGCCCATGAT 
KOP02047 EcoRV-FXC02047 10aa-EcoRI-N ATCATGGGGGACTCAGGATCAAGACGATCTACCG 
KOP02047R EcoRI-FXC02047 10aa-EcoRV-C AATTCGGTAGATCGTCTTGATCCTGAGTCCCCCATGAT 
KOP02078 EcoRV-FXC02078 10aa-EcoRI-N ATCATGGGAGTGGACATCCGCCATAACAAGGACG 
KOP02078R EcoRI-FXC02078 10aa-EcoRV-C AATTCGTCCTTGTTATGGCGGATGTCCACTCCCATGAT 
KOP02452 EcoRV-FXC02452 10aa-EcoRI-N ATCATGGGCAGCCCCTGGAACGGCAGCGACGGCG 
KOP02452R EcoRI-FXC02452 10aa-EcoRV-C AATTCGCCGTCGCTGCCGTTCCAGGGGCTGCCCATGAT 
KOP02617 EcoRV-FXC02617 10aa-EcoRI-N ATCATGGGTGCATTTTTGGATAAACCCAAAACTG 
KOP02617R EcoRI-FXC02617 10aa-EcoRV-C AATTCAGTTTTGGGTTTATCCAAAAATGCACCCATGAT 
KOP02819 EcoRV-FXC02819 10aa-EcoRI-N ATCATGGGAAGAATGTCTTCCAAGCAAGCCACCG 
KOP02819R EcoRI-FXC02819 10aa-EcoRV-C AATTCGGTGGCTTGCTTGGAAGACATTCTTCCCATGAT 
KOP02844 EcoRV-FXC02844 10aa-EcoRI-N ATCATGGGGACTGTGCACGCCCGGAGTTTGGAGG 
KOP02844R EcoRI-FXC02844 10aa-EcoRV-C AATTCCTCCAAACTCCGGGCGTGCACAGTCCCCATGAT 
KOP02940 EcoRV-FXC02940 10aa-EcoRI-N ATCATGGGGAACAGCCACTGTGTCCCTCAGGCCG 
KOP02940R EcoRI-FXC02940 10aa-EcoRV-C AATTCGGCCTGAGGGACACAGTGGCTGTTCCCCATGAT 
KOP02961 EcoRV-FXC02961 10aa-EcoRI-N ATCATGGGCGGCTGCTTCTCCAAACCCAAACCAG 
KOP02961R EcoRI-FXC02961 10aa-EcoRV-C AATTCTGGTTTGGGTTTGGAGAAGCAGCCGCCCATGAT 
KOP03470 EcoRV-FXC03470 10aa-EcoRI-N ATCATGGGGCCCGCGGGGAGCCTGCTGGGCAGCG 
KOP03470R EcoRI-FXC03470 10aa-EcoRV-C AATTCGCTGCCCAGCAGGCTCCCCGCGGGCCCCATGAT 
KOP0-3534 EcoRV-FXC03534 10aa-EcoRI-N ATCATGGGGAGCAAACTGACTTGCTGCCTGGGCG 
KOP03534R EcoRI-FXC03534 10aa-EcoRV-C AATTCGCCCAGGCAGCAAGTCAGTTTGCTCCCCATGAT 
KOP03565 EcoRV-FXC03565 10aa-EcoRI-N ATCATGGGTGCTGGGCCCTCCTTGCTGCTCGCCG 
KOP03565R EcoRI-FXC03565 10aa-EcoRV-C AATTCGGCGAGCAGCAAGGAGGGCCCAGCACCCATGAT 
KOP03640 EcoRV-FXC03640 10aa-EcoRI-N ATCATGGGCAGCGACCCGAGCGCGCCCGGACGGG 
KOP03640 EcoRI-FXC03640 10aa-EcoRV-C AATTCCCGTCCGGGCGCGCTCGGGTCGCTGCCCATGAT 
KOP03765 EcoRV-FXC03765 10aa-EcoRI-N ATCATGGGAGACAAGAAGAGCCCCACCAGGCCGG 
KOP03765R EcoRI-FXC03765 10aa-EcoRV-C AATTCCGGCCTGGTGGGGCTCTTCTTGTCTCCCATGAT 
KOP03868 EcoRV-FXC03868 10aa-EcoRI-N ATCATGGGACAGCAAATTTCGGATCAGACACAGG 
KOP03868R EcoRI-FXC03868 10aa-EcoRV-C AATTCCTGTGTCTGATCCGAAATTTGCTGTCCCATGAT 
KOP03969 EcoRV-FXC03969 10aa-EcoRI-N ATCATGGGAGCGAACACTTCAAGAAAACCACCAG 
KOP03969R EcoRI-FXC03969 10aa-EcoRV-C AATTCTGGTGGTTTTCTTGAAGTGTTCGCTCCCATGAT 
KOP04325 EcoRV-FXC04325 10aa-EcoRI-N ATCATGGGCAATTTACTTAGTAAATTTAGACCCG 
KOP04325R EcoRI-FXC04325 10aa-EcoRV-C AATTCGGGTCTAAATTTACTAAGTAAATTGCCCATGAT 
KOP04954 EcoRV-FXC04954 10aa-EcoRI-N ATCATGGGCTCCTGCGTGTCGCGAGACCTGTTCG 
Table 3-1 (2) 
The nucleotide sequences of oligonucleotides used in this study 
Primer Primer Sequence 
KOP04954R EcoRI-FXC04954 10aa-EcoRV-C AATTCGAACAGGTCTCGCGACACGCAGGAGCCCATGAT 
KOP05791 EcoRV-FXC05791 10aa-EcoRI-N ATCATGGGCTGCTGTGGCTGCTCCAGAGGCTGTG 
KOP05791R EcoRI-FXC05791 10aa-EcoRV-C AATTCACAGCCTCTGGAGCAGCCACAGCAGCCCATGAT 
KOP05792 EcoRV-FXC05792 10aa-EcoRI-N ATCATGGGCTGCTCTGGCTGCTCTGGAGGCTGTG 
KOP05792R EcoRI-FXC05792 10aa-EcoRV-C AATTCACAGCCTCCAGAGCAGCCAGAGCAGCCCATGAT 
KOP05856 EcoRV-FXC05856 10aa-EcoRI-N ATCATGGGGAATATACTGACCTGTTGTATCAACG 
KOP05856R EcoRI-FXC05856 10aa-EcoRV-C AATTCGTTGATACAACAGGTCAGTATATTCCCCATGAT 
KOP05945 EcoRV-FXC05945 10aa-EcoRI-N ATCATGGGTTTGCTCCATTCAGCAGCCCTGGCAG 
KOP05945R EcoRI-FXC05945 10aa-EcoRV-C AATTCTGCCAGGGCTGCTGAATGGAGCAAACCCATGAT 
KOP07187 EcoRV-FXC07187 10aa-EcoRI-N ATCATGGGGAACACATTGGGCCTGGCACCAATGG 
KOP07187R EcoRI-FXC07187 10aa-EcoRV-C AATTCCATTGGTGCCAGGCCCAATGTGTTCCCCATGAT 
KOP07438 EcoRV-FXC07438 10aa-EcoRI-N ATCATGGGGAAAAAACAAAACAAGAAGAAAGTGG 
KOP07438R EcoRI-FXC07438 10aa-EcoRV-C AATTCCACTTTCTTCTTGTTTTGTTTTTTCCCCATGAT 
KOP07771 EcoRV-FXC07771 10aa-EcoRI-N ATCATGGGAGAAGAAGCATCCATTGTGTCTTCAG 
KOP07771R EcoRI-FXC07771 10aa-EcoRV-C AATTCTGAAGACACAATGGATGCTTCTTCTCCCATGAT 
KOP10490 EcoRV-FXC10490 10aa-EcoRI-N ATCATGGGGTCGACCGACTCCAAGCTGAACTTCG 
KOP10490R EcoRI-FXC10490 10aa-EcoRV-C AATTCGAAGTTCAGCTTGGAGTCGGTCGACCCCATGAT 
KOP10528 EcoRV-FXC10528 10aa-EcoRI-N ATCATGGGGCAGGCGGGCTGCAAGGGGCTCTGCG 
KOP10528R EcoRI-FXC10528 10aa-EcoRV-C AATTCGCAGAGCCCCTTGCAGCCCGCCTGCCCCATGAT 
KOP10683 EcoRV-FXC10683 10aa-EcoRI-N ATCATGGGCTGCTGCAGCTCCGCCTCCTCCGCCG 
KOP10683R EcoRI-FXC10683 10aa-EcoRV-C AATTCGGCGGAGGAGGCGGAGCTGCAGCAGCCCATGAT 
KOP10889 EcoRV-FXC10889 10aa-EcoRI-N ATCATGGGCAGTGTGCGAACCAACCGCTACAGCG 
KOP10889R EcoRI-FXC10889 10aa-EcoRV-C AATTCGCTGTAGCGGTTGGTTCGCACACTGCCCATGAT 
KOP11186 EcoRV-FXC11186 10aa-EcoRI-N ATCATGGGCTGCTGTGGCTGTTCCGAAGGCTGTG 
KOP11186R EcoRI-FXC11186 10aa-EcoRV-C AATTCACAGCCTTCGGAACAGCCACAGCAGCCCATGAT 
KOP11187 EcoRV-FXC11187 10aa-EcoRI-N ATCATGGGCTGTTGCGGCTGCTCCGGAGGCTGTG 
KOP11187 EcoRI-FXC11187 10aa-EcoRV-C AATTCACAGCCTCCGGAGCAGCCGCAACAGCCCATGAT 
KOP11232 EcoRV-FXC11232 10aa-EcoRI-N ATCATGGGAGCAGTAAGCTGTCGGCAGGGGCAGG 
KOP11232R EcoRI-FXC11232 10aa-EcoRV-C AATTCCTGCCCCTGCCGACAGCTTACTGCTCCCATGAT 
KOP11252 EcoRV-FXC11252 10aa-EcoRI-N ATCATGGGCGGGAACCACTCCCACAAGCCCCCCG 
KOP11252R EcoRI-FXC11252 10aa-EcoRV-C AATTCGGGGGGCTTGTGGGAGTGGTTCCCGCCCATGAT 
KOP11288 EcoRV-FXC11288 10aa-EcoRI-N ATCATGGGTGACAAGGGAACAGGCAACCATTCAG 
KOP11288R EcoRI-FXC11288 10aa-EcoRV-C AATTCTGAATGGTTGCCTGTTCCCTTGTCACCCATGAT 
KOP11366 EcoRV-FXC11366 10aa-EcoRI-N ATCATGGGCTGCAGAAGAACTAGAGAAGGACCAG 
KOP11366R EcoRI-FXC11366 10aa-EcoRV-C AATTCTGGTCCTTCTCTAGTTCTTCTGCAGCCCATGAT 
KOP11932 EcoRV-FXC11932 10aa-EcoRI-N ATCATGGGAGACCCGGGGTCGGAAATAATAGAAG 
KOP11932R EcoRI-FXC11932 10aa-EcoRV-C AATTCTTCTATTATTTCCGACCCCGGGTCTCCCATGAT 
Table 3-1 (3) 
The nucleotide sequences of oligonucleotides used in this study 
Primer Primer Sequence 
Primer-N2 EcoRI-FXC1999-N GCATGAATTCATGGGCGCGAACAATG 
Primer-C2 FXC1999-Flag-XbaI-C GCGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCGAAGAAAGCCGGGTT 
Primer-N3 EcoRV- FXC02617-N GCATGATATCATGGGTGCATTTTTG 
Primer-C3 FXC02617-Flag-EcoRI-C GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCTATTTTTTCACCACT 
Primer-N4 BamHI-FXC2844-N ATATGGATCCATGGGGACTGTGCAC 
Primer-C4 FXC2844-Flag-XbaI-C GCGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCCAGGAACCTTATCCC 
Primer-N5 EcoRV- FXC02940-N GATAGATATCATGGGGAACAGCCAC 
Primer-C5 FXC02940-Flag-EcoRI-C GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCGATCCACTGCACAAG 
Primer-N6 EcoRI-FXC03470-N ATATGAATTCATGGGGCCCGCGGGG 
Primer-C6 FXC03470-Flag-stop-XbaI-C GCGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCGAGCCTGGTAATATC 
Primer-N7 EcoRV-FXC03534-N GTACGATATCATGGGGAGCAAACTG 
Primer-C7 FXC03534-Flag-stop-EcoRI AGGGGAATTCTTACTTGTCATCGTCATCCTTGTAGTCAAGCCGGAGAAGTCC 
Primer-N8 EcoRV-FXC3565-N ATATGATATCATGGGTGCTGGGCCC 
Primer-C8 FXC3565-Flag-XbaI-C GCGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCCAATTTAGGAATTGG 
Primer-N9 EcoRI-FXC03868-N GCGCGAATTCATGGGACAGCAAATT 
Primer-C9 FXC03868-Flag-XbaI-C ATGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCTGGCCTGTGGGGCTG 
Primer-N10 EcoRV- FXC03969-N GATAGATATCATGGGAGCGAACACT 
Primer-C10 FXC03969- Flag-EcoRI-C GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCCAAGTTGTTATTCTG 
Primer-N11 EcoRI-FXC04954-N ATATGAATTCATGGGCTCCTGCGTG 
Primer-C11 FXC04954-Flag-stop-XbaI-C GCGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCGTTATAGAACACCTC 
Primer-N12 EcoRI-FXC05856-N GCGCGAATTCATGGGGAATATACTG 
Primer-C12 FXC05856-Flag-stop-XbaI-C GCGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCCCCTGGATGAATCTC 
Primer-N13 EcoRV- FXC05945-N GCATGATATCATGGGTTTGCTCCAT 
Primer-C13 FXC05945- Flag-EcoRI-C GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCAAGCGAAGTTTCATT 
Primer-N14 EcoRI- FXC07187-N GCGCGAATTCATGGGGAACACATTG 
Primer-C14 FXC07187- Flag-BamHI-C GCGAGGATCCTTACTTGTCATCGTCATCCTTGTAGTCGCCCACAGTGATGCT 
Primer-N15 EcoRV- FXC10490-N ATATGATATCATGGGGTCGACCGAC 
Primer-C15 FXC10490- Flag-EcoRI-C GCGAGAATTCTTACTTGTCATCGTCATCCTTGTAGTCCACCCGCTGTATCTC 
Primer-N16 EcoRV-MGQ-ORK10528 N ATATGATATCATGGGGCAGGCGGGCTGCAAGGGG 
Primer-C16 ORK10528-Flag-stop-EcoRI GCGCGAATTCTTACTTACTTGTCATCGTCATCCTTGTAGTCCGTGCTCCTGTGGGG 
Primer-N17 EcoEV-FXC10683-N ATATGATATCATGGGCTGCTGCAGC 
Primer-C17 FXC10683-Flag-XbaI-C GCGCTCTAGATTACTTGTCATCGTCATCCTTGTAGTCAGCAGAACTTGCTCC 
Primer-N18 EcoRV-FXC11232-N ATGCGATATCATGGGAGCAGTAAGC 
Primer-C18 FXC11232-Flag-EcoRI-C GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCACCTCTCTCACCCAT 
Primer-N19 EcoRV- FXC11252-N GCATGATATCATGGGCGGGAACCAC 
Primer-C19 FXC11252- Flag-SacI-C GCGAGAGCTCTTACTTGTCATCGTCATCCTTGTAGTCGCTGCTGCAGCCACG 
Primer-C20 FXC02617- XbaI-C GCGCTCTAGATATTTTTTCACCACT 
Table 3-1 (4) 
The nucleotide sequences of oligonucleotides used in this study 
Primer Primer Sequence 
Primer-N20 BamHI-FXC2844G2A-N ATATGGATCCATGGCCACTGTGCACGCCCGG 
Primer-C21 FXC02940- XbaI-C GCATTCTAGAGATCCACTGCACAAG 
Primer-N21 EcoRI-AIF3 N GCGCGAATTCATGGGCGGCTGCTTC 
Primer-C22 Flag-EcoRV C GCGCGAATTCTTACTTGTCATCGTC 
Primer-N22 BamHI-FXC03534-N AATTGGATCCATGGGGAGCAAACTG 
Primer-C23 FXC03969- XbaI-C GCGCTCTAGACAAGTTGTTATTCTG 
Primer-C24 FXC05945- XbaI-C GCGCTCTAGAAAGCGAAGTTTCATT 
Primer-N23 BamHI- FXC07187-N GCATGGATCCATGGGGAACACATTG 
Primer-C25 FXC07187- EcoRI-C GCATGAATTCGCCCACAGTGATGCT 
Primer-C26 FXC10490- XbaI-C GATATCTAGACACCCGCTGTATCTC 
Primer-N24 EcoRI-FXC10528-N ATATGAATTCATGGGGCAGGCGGGC 
Primer-C27 FXC10528-XbaI-C ATATTCTAGACGTGCTCCTGTGGGG 
Primer-N25 HindIII- FXC10683-N ATGCAAGCTTATGGGCTGCTGCAGC 
Primer-C28 FXC10683-XbaI-C GCGCTCTAGAAGCAGAACTTGCTCC 
Primer-N26 HindIII- FXC11252-N GCATAAGCTTATGGGCGGGAACCAC 
Primer-C29 FXC11252- EcoRV-C GATCGATATCGCTGCTGCAGCCACG 
Table 3-2 (1) The strategies for construction of pTD1 or pcDNA3 plasmids including fulllength KOP cDNA clones. 
Name of plasmid Strategy for plasmid construction 
pTD1- 10aa-tAct-Flag Product of a PCR with pDT1-tAct-Flag as a template and primers Primer-N1 and 
Primer-C1 was EcoRI/XbaI cloned into pTD1. 
pTD1-FXC01999-FLAG 
Product of a PCR with pF1KA0840 as a template and primers Primer-N2 and Primer-C2 
was EcoRI/XbaI cloned into pTD1. 
pTD1-FXC02617-FLAG Product of a PCR with pF1KB8150 as a template and primers Primer-N3 and Primer-C3
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC02844-FLAG Product of a PCR with pF1KB8447 as a template and primers Primer-N4 and Primer-C4
was BamHI/XbaI cloned into pTD1. 
pTD1-FXC02940-FLAG Product of a PCR with pF1KB8695 as a template and primers Primer-N5 and Primer-C5
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC02961-FLAG pTD1-FL vector was digested with SgfI and EcoICRI and the KOP cDNA clones digested 
with SgfI and PmeI were subcloned into the vector. 
pTD1-FXC03470-FLAG Product of a PCR with pF1KB6612 as a template and primers Primer-N6 and Primer-C6
was EcoRI/XbaI cloned into pTD1. 
pTD1-FXC03534-FLAG Product of a PCR with pF1KE0505 as a template and primers Primer-N7 and Primer-C7
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC03565-FLAG 
Product of a PCR with pF1KB5535 as a template and primers Primer-N8 and Primer-C8
was EcoRV/XbaI cloned into pTD1. 
pTD1-FXC03868-FLAG Product of a PCR with pF1KB0979 as a template and primers Primer-N9 and Primer-C9
was EcoRI/XbaI cloned into pTD1. 
pTD1-FXC03969-FLAG Product of a PCR with pF1KE0678 as a template and primers Primer-N10 and Primer-C10
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC4954-FLAG 
Product of a PCR with pF1KB6310 as a template and primers Primer-N11 and Primer-C11
was EcoRI/XbaI cloned into pTD1. 
pTD1-FXC05856-FLAG Product of a PCR with pF1KE0523 as a template and primers Primer-N12 and Primer-C12 
was EcoRI/XbaI cloned into pTD1. 
pTD1-FXC05945-FLAG Product of a PCR with pF1KE0011 as a template and primers Primer-N13 and Primer-C13
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC07187-FLAG 
Product of a PCR with pF1KE0451 as a template and primers Primer-N14 and Primer-C14
was EcoRI/BamHI cloned into pTD1. 
pTD1-FXC10490-FLAG Product of a PCR with pF1KB9562 as a template and primers Primer-N15 and Primer-C15
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC10528-FLAG Product of a PCR with pF1KB4832 as a template and primers Primer-N16 and Primer-C16
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC10683-FLAG 
Product of a PCR with pF1KB9940 as a template and primers Primer-N17 and Primer-C17
was EcoRV/XbaI cloned into pTD1. 
pTD1-FXC11232-FLAG Product of a PCR with pF1KE0683 as a template and primers Primer-N18 and Primer-C18
was EcoRV/EcoRI cloned into pTD1. 
pTD1-FXC11252-FLAG Product of a PCR with F1KE0720 as a template and primers Primer-N19 and 
Primer-C219was EcoRV/SacI cloned into pTD1. 
pcDNA3-FXC01999-FLAG 
Product of a PCR with pF1KA0840 as a template and primers Primer-N2 and Primer-C2 
was EcoRI/XbaI cloned into pcDNA3-Flag. 
Table 3-2 (2) The strategies for construction of pTD1 or pcDNA3 plasmids including fulllength KOP cDNA clones.
Name of plasmid Strategy for plasmid construction 
pcDNA3-FXC02617-FLAG Product of a PCR with pF1KB8150 as a template and primers Primer-N3 and Primer-C20
was EcoRV/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC02844-FLAG Product of a PCR with pF1KB8447 as a template and primers Primer-N4 and Primer-C4
was BamHI/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC02844G2A-FLAG Product of a PCR with pF1KB8447 as a template and primers Primer-N20 and Primer-C4
was BamHI/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC02940-FLAG Product of a PCR with pF1KB8695 as a template and primers Primer-N5 and Primer-C21
was EcoRV/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC02961-FLAG Product of a PCR with pF1KB8718 as a template and primers Primer-N21 and Primer-C22
was EcoRI/EcoRV cloned into pcDNA3-Flag. 
pcDNA3-FXC03470-FLAG Product of a PCR with pF1KB6612 as a template and primers Primer-N6 and Primer-C6
was EcoRI/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC03534-FLAG Product of a PCR with pF1KE0505 as a template and primers Primer-N22 and Primer-C7
was EcoRV/EcoRI cloned into pcDNA3-Flag. 
pcDNA3-FXC03565-FLAG 
Product of a PCR with pF1KB5535 as a template and primers Primer-N8 and Primer-C8
was EcoRV/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC03868-FLAG Product of a PCR with pF1KB0979 as a template and primers Primer-N9 and Primer-C9
was EcoRI/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC03969-FLAG Product of a PCR with pF1KE0678 as a template and primers Primer-N10 and Primer-C23
was EcoRV/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC4954-FLAG 
Product of a PCR with pF1KB6310 as a template and primers Primer-N11 and Primer-C11
was EcoRI/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC05856-FLAG Product of a PCR with pF1KE0523 as a template and primers Primer-N12 and Primer-C12 
was EcoRI/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC05945-FLAG Product of a PCR with pF1KE0011 as a template and primers Primer-N13 and Primer-C24
was EcoRV/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC07187-FLAG 
Product of a PCR with pF1KE0451 as a template and primers Primer-N23 and Primer-C25
was BamHI/EcoRI cloned into pcDNA3-Flag. 
pcDNA3-FXC10490-FLAG Product of a PCR with pF1KB9562 as a template and primers Primer-N15 and Primer-C26
was EcoRV/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC10528-FLAG Product of a PCR with pF1KB4832 as a template and primers Primer-N24 and Primer-C27
was EcoRI/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC10683-FLAG 
Product of a PCR with pF1KB9940 as a template and primers Primer-N25 and Primer-C28
was HindIII/XbaI cloned into pcDNA3-Flag. 
pcDNA3-FXC11232-FLAG Product of a PCR with pF1KE0683 as a template and primers Primer-N18 and Primer-C18
was EcoRV/XhoI cloned into pcDNA3-Flag. 
pcDNA3-FXC11252-FLAG Product of a PCR with F1KE0720 as a template and primers Primer-N26 and Primer-C29




Table 3-3. The results of the prediction for protein N-myristoylation of 90 cDNA clones using two prediction 
programs, The MYR Predictor and Myristoylator. 
No. FXC No. Gene name MYR Myristoylator
1 FXC01999 FBXL7 Twilight No
2 FXC02047 KIAA1680 No Low 
3 FXC02078 RPL18 No Low 
4 FXC02087 PSMC1 Reliable High 
5 FXC02096 MBP Twilight High 
6 FXC02112 GNAO1 Reliable High 
7 FXC02124 ARF6  Reliable High 
8 FXC02148 GNAZ Reliable High 
9 FXC02199 HPCAL1 Reliable High 
10 FXC02452 MLNR  No Medium 
11 FXC02617 PPM1B No Medium 
12 FXC02691 ARF4 Reliable High 
13 FXC02705 CIB1 Reliable High 
14 FXC02814 ZNRF1 Reliable No
15 FXC02819 SOX6 No High 
16 FXC02830 SCYL3 Reliable High 
17 FXC02835 PRKACB Reliable High 
18 FXC02843 CYB5R3 Reliable High 
19 FXC02844 SAMM50 No Medium 
20 FXC02903 CCNY Reliable High 
21 FXC02940 PLEKHN Reliable Low 
22 FXC02961 AIFM3 Reliable High 
23 FXC02992 ARL11 Reliable Medium 
24 FXC02995 ARL4A  No High 
25 FXC02996 ARL4D No Low 
26 FXC03133 ARL4C Reliable Low 
27 FXC03149 MARCKS Reliable High 
28 FXC03406 KCNIP1 Reliable No
29 FXC03442 FRS2 Reliable High 
30 FXC03444 LYN Reliable High 
31 FXC03470 PAG1 No High 
32 FXC03513 GORASP1 Reliable High 
33 FXC03534 C22orf42 Twilight High 
34 FXC03565 CTSC No Low 
35 FXC03640 MMP15 No High 
36 FXC03679 SLA2 Reliable High 
37 FXC03685 PDE9A Twilight High 
38 FXC03736 LCK Reliable High 
39 FXC03765 YAF2 No High 
40 FXC03808 BLK Reliable High 
41 FXC03815 RAPSN Reliable High 
42 FXC03868 RNF141 No High 
43 FXC03887 PPP3R1 Reliable High 
44 FXC03909 GMCL1 Twilight High 
45 FXC03969 STK32A Twilight High 
No. FXC No. Gene name MYR Myristoylator
46 FXC04325 C15orf2 Reliable High 
47 FXC04954 FAM131C Reliable High 
48 FXC05230 NCS1 Reliable High 
49 FXC05310 GNAI2 Reliable High 
50 FXC05311 GNAI3 Reliable High 
51 FXC05451 HPCAL4 Reliable High 
52 FXC05791 KRTAP5-2 Twilight No 
53 FXC05792 KRTAP5-3 Twilight No 
54 FXC05793 KRTAP5-4 Twilight No 
55 FXC05856 DRICH1 Twilight High 
56 FXC05932 MARCKSL1 Reliable High 
57 FXC05945 MCC1 No High 
58 FXC06109 NCALD  Reliable High 
59 FXC06445 PPEF2 Reliable High 
60 FXC06481 PRKACG Reliable High 
61 FXC06491 PRKG2 Reliable Medium 
62 FXC07187 TOMM40L Twilight Medium 
63 FXC07438 CBX1 No High 
64 FXC07768 CHCHD3 Reliable High 
65 FXC07771 ZNF292 No High 
66 FXC07968 ARL5A No High 
67 FXC08024 RCVRN) Reliable High 
68 FXC08348 GORASP2 Reliable High 
69 FXC10143 VSNL1) Reliable High 
70 FXC10490 HID1 No High 
71 FXC10528 P2RX5 Reliable High 
72 FXC10564 PRKACA Reliable High 
73 FXC10600 DUSP22 No High 
74 FXC10609 ARF3 Twilight High 
75 FXC10612 CIB2 Reliable High 
76 FXC10616 ARF5 Reliable High 
77 FXC10683 SLC44A1 Reliable High 
78 FXC10684 FYN Reliable High 
79 FXC10889 KCNJ2 Twilight No 
80 FXC10897 CHP2 Twilight High 
81 FXC10914 CABP2 No Medium 
82 FXC11186 KRTAP5-7 Twilight No 
83 FXC11187 KRTAP5-1 Twilight No 
84 FXC11232 SGK494 Reliable No 
85 FXC11252 STK32B Twilight High 
86 FXC11260 PSKH1 Reliable High 
87 FXC11288 OR9K1P No Medium 
88 FXC11366 SELL Twilight No 
89 FXC11854 SRC Reliable High 
90 FXC11932 KIAA1586 No High 
Fig. 3-1. Selection of candidate cDNA clones encoding human N-myristoylated proteins from a cDNA 
resource.  
A. Strategy for selection of candidate cDNA clones encoding human N-myristoylated proteins from a cDNA 
resource. B. Schematic representation of the generation of NNNNN-tActin-FLAG with N-terminal 10 amino 
acid sequences of the ORFs of KOP cDNA clones at its N-terminus. C. Detection of protein N-myristoylation of 
NNNNN-tActin-FLAGs by metabolic labeling in an insect cell-free protein synthesis system. NNNNN-tActin-
FLAGs were synthesized in the presence of [3H]leucine or [3H]myristic acid, and the labeled translation 
products were analyzed by SDS-PAGE and fluorography. The myristoylated samples are indicated by red 
circles. The results of the predictions of protein N-myristoylation using two prediction programs, The MYR 
Predictor and Myristoylator, are shown in the lower panels. R, T, and blank represent 
 and  prediction from The MYR Predictor, respectively. H, M, L, and blank represent 
 and  predictions from Myristoylator, respectively. 
Table 3-4. The list of cDNA samples analyzed in Fig. 3-1. 
Fig. 3-2. Detection of protein N-myristoylation of the gene products of 19 full-length cDNAs by 
metabolic labeling in an insect cell-free protein synthesis system and in transfected HEK293T cells. 
 A. The gene products of 19 full-length cDNAs, in which efficient incorporation of [3H]myristic acid was 
observed with the tActin fusion proteins, were synthesized using an insect cell-free protein synthesis 
system in the presence of [3H]leucine or [3H]myristic acid. The labeled translation products were analyzed 
by SDS-PAGE and fluorography. Faint bands are indicated by arrowheads. B. The 19 full-length cDNAs 
analyzed in Fig. 3-2 A were transfected into HEK293T cells, and metabolic labeling with [3H]myristic acid 
was performed. The labeled translation products were separated by SDS-PAGE and then analyzed by 
western blotting using an anti-FLAG antibody or fluorography. The samples that showed no protein 
expression are indicated by blue circles in the upper panels. The samples in which protein N-myristoylation 
was observed are indicated by red boxes in the lower panels. Faint bands are indicated by arrowheads. 
Table 3-5. The list of cDNA samples analyzed in Figs 3-2 and 3-3. 
Lane FXC No. Gene name
1 FXC01999 FBXL7
2 FXC02617 PPM1B 
3 FXC02844 SAMM50 
4 FXC02940 PLEKHN 
5 FXC02961 AIFM3 
6 FXC03470 PAG1 
7 FXC03534 C22orf42 
8 FXC03565 CTSC 
9 FXC03868 RNF141
10 FXC03969 STK32A 
11 FXC04954 FAM131C 
12 FXC05856 DRICH1 
13 FXC05945 MCC1 
14 FXC07187 TOMM40L 
15 FXC10490 HID1 
16 FXC10528 P2RX5 
17 FXC10683 SLC44A1 
18 FXC11232 SGK494 
19 FXC11252 STK32B 

Fig. 3-3. Comparison of the molecular size of [3H]myristic acid-labeled protein bands 
detected in transfected HEK293T cells with those detected in the insect cell-free protein 
synthesis system.  
The molecular sizes of [3H]myristic acid-labeled protein bands expressed in the two 
expression systems were compared with each other by SDS-PAGE analysis. The samples in 
which similar molecular sizes were observed are indicated by red circles. Faint bands are 
indicated by arrowheads. F; insect cell-free, C; HEK293T cells. 
Fig. 3-4 Comparison of the molecular size of [3H]myristic acid-labeled protein bands detected in 
transfected HEK293T cells with those detected in the insect cell-free protein synthesis system.  
The overexposed fluorograms of the fluorography data of Fig 3-3 are shown to demonstrate the 
presence of protein bands in lanes 2, 4 and 10. 


Fig. 3-5. Protein N-myristoylation is required for proper targeting of SAMM50 to mitochondria. 
 A. Interspecies alignment of the N-terminal sequences of SAMM50. N-myristoylation motifs are shown in grey in the 
N-terminal sequence. B. Detection of protein N-myristoylation of SAMM50 expressed in COS-1 cells. cDNAs 
encoding SAMM50-FLAG and SAMM50-G2A-FLAG were transfected into COS-1 cells. Their expression and the 
N-myristoylation of the products in total cell lysates were evaluated by western blotting analysis and [3H]myristic acid 
labeling, respectively. C. Intracellular localization of SAMM50-FLAG and SAMM50-G2A-FLAG was determined by 
immunofluorescence staining of COS-1 cells transfected with cDNAs encoding these two proteins using an anti-
SAMM50 antibody. Mitochondria were detected using MitoTracker Red. Lower panels show a close-up image. D. 
Quantitative analysis of the intracellular localization of SAMM50-FLAG and SAMM50-G2A-FLAG. cDNAs 
encoding thiese two proteins were transfected into COS-1 cells and the intracellular localization was determined by 
immunofluorescence staining. Quantitative analysis of the mitochondrial localization was performed by fluorescence 
microscopic observation of 50 immunofluorescence-positive cells. The extent of mitochondrial localization was 
expressed as a percentage of the number of cells in which selective localization to mitochondria, localization to 
mitochondria and cytoplasm, and selective localization to cytoplasm was observed against the total number of
transfected cells. Data are expressed as mean  SD for five independent experiments. **P < 0.001 vs. wild-type. 
Anti-SAMM50

Fig. 3-6. Endogenous SAMM50 expressed in COS-1 cells is N-myristoylated. Metabolic labeling of 
endogenous SAMM50 expressed in COS-1 cells with [3H]myristic acid was performed.  
Tag-free-SAMM50 exogenously expressed in COS-1 cells was used as a control. A. Expression of 
exogenously expressed Tag-free-SAMM50 and endogenous SAMM50 in COS-1 cells was determined by 
western blotting analysis using an anti-SAMM50 antibody. B. Protein Nmyristoylation of exogenously 
expressed Tag-free-SAMM50 and endogenous SAMM50 in COS-1 cells was determined by [3H]myristic 
acid labeling. MW; molecular weight marker, IP; immunoprecipitated with anti-SAMM50 antibody. Upper 
and lower panels show the result of C.B.B.-staining and fluorography, respectively. Arrowheads in the upper 
panel indicate the position of heavy chain of IgG used for immunoprecipitation. 
Fig. 3-7 The result of western blotting analysis of 4 samples analyzed in Fig. 3-6 B is shown. 










Fig. 4-1. Schematic representation of cellular and cell-free detection systems for protein N- yristoylation 
by metabolic labeling utilizing bioorthogonal myristic acid analogues.  
A. Metabolic labeling in cultured mammalian cells. B. Metabolic labeling in cell-free protein synthesis 
system. In both detection systems, metabolically labeled proteins with myristic acid analogues were reacted 
with biotin-tags via CuAAC for gel-based analysis. The recommended concentrations of reagents and reaction 
times were indicated.C. Chemical structures of alkynyl- or azide-analogues of myristic acid and detection 
tags. 1. [3H]myristic acid, 2. alkynyl-analogue of myristic acid (Alk-Myr), 3. azide-analogue of myristic acid 
(Az-Myr), 4. azide-biotin (Az-Biotin), 5. Alkynyl-biotin (Alk-Biotin) 
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Primer- N3 - GATAGATATCATGGGAGCGAACACT -
Primer-C2 - GCGCTCTAGACAAGTTGTTATTCTG -
Primer- N4 -GCGCGATATCATGGCGGCGAACACTTCAAGA-
Primer- N5 - ATATGATATCATGGGGTCGACCGAC -
Primer-C3 - GATATCTAGACACCCGCTGTATCTC -
Primer- N6 -ATATGATATCATGGCGTCGACCGACTCCAAG -
Primer- N7 -GTATGGATCCATGGGCAGTGTGCGA-3 
Primer-C4 - GCGCGAATTCTATCTCCGACTCTCG -
Primer-N8 -GCATGATATCATGGGCCAGGTCATC- 
Primer-C5 - GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCGAAGCATTTGCGGTG- 
Primer-N9 -GCGCGATATCATGGCCCAGGTCATCACCATT -
Primer-C6 -GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCGATCCACTGCACAAG-
Primer-C7 - GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCCAAGTTGTTATTCTG -
Primer-C8 - GCGAGAATTCTTACTTGTCATCGTCATCCTTGTAGTCCACCCGCTGTATCTC -
Primer- N10 - GATAGATATCATGGGCAGTGTGCGA -
Primer-C9 - GCGCGAATTCTTACTTGTCATCGTCATCCTTGTAGTCTATCTCCGACTCTCG -

Table 4-2 Strategies for construction of plasmids used in this study. 
Name of plasmid Strategy for plasmid construction 
pcDNA3-FXC02940-FLAG 
Product of a PCR with pF1KB8690 (Promega) as a template and primers 
Primer-N1 and Primer-C1 was EcoRV/XbaI cloned into pcDNA3-FLAG. 
pcDNA3-FXC02940G2A-FLAG 
Product of a PCR with pF1KB8690 as a template and primers Primer-N2 
and Primer-C1 was EcoRV/XbaI cloned into pcDNA3-FLAG. 
pcDNA3-FXC03969-FLAG 
Product of a PCR with pF1KE0678 as a template and primers Primer-N3 
and Primer-C2 was EcoRV/XbaI cloned into pcDNA3-FLAG. 
pcDNA3-FXC03969G2A-FLAG 
Product of a PCR with pF1KE0678 as a template and primers Primer-N4 
and Primer-C2 was EcoRV/XbaI cloned into pcDNA3-FLAG. 
pcDNA3-FXC10490-FLAG 
Product of a PCR with pF1KB9562 as a template and primers Primer-N5 
and Primer-C3 was EcoRV/XbaI cloned into pcDNA3-FLAG. 
pcDNA3-FXC10490G2A-FLAG 
Product of a PCR with pF1KB9562 as a template and primers Primer-N6 
and Primer-C3 was EcoRV/XbaI cloned into pcDNA3-FLAG. 
pcDNA3-FXC10889-FLAG 
Product of a PCR with pF1KE0241 as a template and primers Primer-N7 
and Primer-C4 was BamHI/EcoRI cloned into pcDNA3-FLAG. 
pTD1-tActin-FLAG 
Product of a PCR with pcDNA3-tActin-FLAG as a template and primers 
Primer-N8 and Primer-C5 was EcoRV/EcoRI, cloned into pTD1. 
pTD1-tActinG2A-FLAG 
Product of a PCR with pcDNA3-tActin-FLAG as a template and primers 
Primer-N9 and Primer-C5 was EcoRV/EcoRI, cloned into pTD1. 
pTD1-FXC02940-FLAG 
Product of a PCR with pF1KB8690 as a template and primers Primer-N1 
and Primer-C6 was EcoRV/EcoRI, cloned into pTD1. 
pTD1-FXC03969-FLAG 
Product of a PCR with pF1KE0678 as a template and primers Primer-N3 
and Primer-C7 was EcoRV/EcoRI, cloned into pTD1. 
pTD1-FXC10490-FLAG 
Product of a PCR with pF1KB9562 as a template and primers Primer-N5 
and Primer-C8 was EcoRV/EcoRI, cloned into pTD1. 
pTD1-FXC10889-FLAG 
Product of a PCR with pF1KB8690 as a template and primers Primer-N10 




Fig. 4-2. Protein N-myristoylation is efficiently detected in a cell-free protein synthesis system by 
metabolic labeling with bioorthogonal myristic acid analogues.  
A. Detection of protein N-myristoylation of tActin by metabolic labeling in HEK293T cells. cDNAs encoding 
tActin- and tActinG2A-FLAG were transfected into HEK293T cells, then the cells were labeled with myristic 
acid analogues or [3H]myristic acid. The expression of proteins was evaluated by western blotting analysis using 
anti-FLAG antibody (a, c, and e). Protein N-myristoylation was evaluated by metabolic labeling with myristic 
acid analogues followed by CuAAC with detection tags (b and d) or [3H]myristic acid (f), respectively, as 
described in the materials and methods. Two myristic acid analogues, Alk-Myr (a and b) and Az-Myr (c and d), 
were used for the analysis. B. Detection of protein N-myristoylation of tActin by metabolic labeling in an insect 
cell-free protein synthesis system. mRNAs encoding tActin- and tActinG2A-FLAG were translated in vitro in 
the presence of myristic acid analogues or [3H]leucine, [3H]myristic acid using an insect cell-free protein 
synthesis system. The expression of protein was evaluated by western blotting analysis using an anti-FLAG 
antibody (a and c) or incorporation of [3H]leucine (e). Protein N-myristoylation was evaluated by metabolic 
labeling with myristic acid analogues followed by CuAAC with detection tags (b and d) or [3H]myristic acid (f), 
respectively. Two myristic acid analogues, Alk-Myr (a and b) and Az-Myr (c and d) were used for the analysis. 














































a b c d

Fig. 4-3. An azide-analogue of myristic acid is suitable for the detection of protein N-myristoylation by 
metabolic labeling in an insect cell-free protein synthesis system.  
The effect of concentration of myristic acid analogues in metabolic labeling and biotin-tags in the CuAAC 
reaction on the detection efficiency of protein N-myristoylation of tActin-FLAG in an insect cell-free protein 
synthesis system was evaluated. A. mRNAs encoding tActin-FLAG were translated in vitro in the presence of 
various concentrations of Alk-Myr or Az-Myr using an insect cell-free protein synthesis system, followed by 
reaction with biotin tags at 0.1 mM via CuAAC. B. mRNAs encoding tActin-FLAG were translated in vitro in the 
presence of 50 mM Alk-Myr or Az-Myr using an insect cell-free protein synthesis system, followed by reaction 
with various concentrations of Az-biotin or Alk-biotin, respectively, via CuAAC. The expression of protein was 
evaluated by western blotting analysis using an anti-FLAG antibody. Protein N-myristoylation was detected by 
ECL using streptavidin-HRP as described in the materials and methods. Quantitative analysis of the labeled 
proteins was carried out by scanning the blots using a MicroChemi Chemiluminescence Imaging System. Relative 
detection efficiency was calculated as (intensity of metabolic labeling with myristic acid analogue)/(intensity of 
anti-FLAG western blotting) of each protein band. The highest relative detection efficiency was set as 100% and 
the relative detection efficiency of each sample is shown (lower panels). Data are expressed as mean  SD for 











































Fig. 4-4. The insect cell-free protein synthesis system is optimal for the cell-free detection of protein N-
myristoylation. 
 mRNAs encoding tActin- and tActinG2A-FLAG were translated in vitro in the presence of [3H]leucine, 
[3H]myristic acid, or Az-Myr using an insect cell-free protein synthesis system (A) or a rabbit reticulocyte 
lysate system (B). The expression level of protein was evaluated by incorporation of [3H]leucine (a) or western 
blotting analysis using an anti-FLAG antibody (c). Protein N-myristoylation was evaluated by metabolic 
labeling with [3H]myristic acid (b) or Az-Myr followed by CuAAC with Alk-Biotin (d), respectively, as 
described in the materials and methods. CBB-staining of the SDS-PAGE gel or the blotted membrane was used 
as a loading control (lower panels). 
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Table 4-3. The characteristics of the gene products of the 4 cDNA clones analyzed in this study. 
FXC 
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The results of the prediction of protein N-myristoylation of the four cDNA clones using two prediction 
programs, The MYR Predictor and Myristoylator, are shown. 

Fig. 4-6.  Identification of novel N-myristoylated proteins from human cDNA resources by metabolic 
labeling in the insect cell-free protein synthesis system using a bioorthogonal myristic acid analogue. 
 A. Detection of protein N-myristoylation of four candidate proteins by metabolic labeling in HEK293T cells. 
cDNAs encoding tActin, PLEKHN1, STK32A, HID1, and KCNJ2 were transfected into HEK293T cells, then, 
the cells were labeled with [3H]myristic acid or Az-Myr. The expression of protein was evaluated by western 
blotting analysis using an anti-FLAG antibody (a and c). Protein N-myristoylation was evaluated by metabolic 
labeling with [3H]myristic acid (b) or Az-Myr followed by CuAAC with Alk-biotin (d), as described in the 
materials and methods. B. Detection of protein N-myristoylation of four candidate proteins by metabolic labeling 
in an insect cell-free protein synthesis system. mRNAs encoding tActin, PLEKHN1, STK32A, HID1, and 
KCNJ2 were translated in vitro in the presence of [3H]leucine, [3H]myristic acid, or Az-Myr using an insect cell-
free protein synthesis system. The expression of protein was evaluated by incorporation of [3H]leucine (a) or 
western blotting analysis using an anti-FLAG antibody (c). Protein N-myristoylation was evaluated by metabolic 
labeling with [3H]myristic acid (b) or Az-Myr followed by azide-alkyne cycloaddition with Alk-biotin (d), as 
described in the materials and methods.  
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Fig. 4-7.  Protein N-myristoylation strongly affects the intracellular localization of novel N-myristoylated 
proteins.  
A. cDNAs encoding wild-type and G2A mutants of tActin, PLEKHN1, STK32A, and HID1 were transfected 
into HEK293T cells, then the cells were labeled with Az-Myr. The expression of protein was evaluated by 
western blotting analysis using an anti-FLAG antibody (lower panels). Protein N-myristoylation was evaluated 
by CuAAC with Alk-biotin, followed by detection with ECL using streptavidin-HRP (upper panels), as 
described in the materials and methods. B. cDNAs encoding wild-type and G2A mutants of tActin, PLEKHN1, 
and STK32A were transfected into HEK293T cells, and the intracellular localization of the expressed proteins 
was determined by immunofluorescence staining using an anti-FLAG antibody. 
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